Credit Capital Investments’s Merck MRK Stock Holding History

Credit Capital Investments’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,000	Closed	-$613K	–	69
2021 Q4	$613K	Buy	+8,000	New	+$637K	0.6%	32

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Credit Capital Investments's MRK Position: Q1 2022 in Review

Credit Capital Investments sold out of Merck (MRK) in Q1 2022, closing a stake of 8,000 shares — an estimated $613K sold.

Credit Capital Investments first reported a position in MRK in Q4 2021 and held it in 1 quarter. The position peaked at $613K in Q4 2021. 2,953 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

Credit Capital Investments reported no remaining Merck position as of Q1 2022 after selling out during the quarter.
Credit Capital Investments sold 8,000 Merck shares in Q1 2022, an estimated $613K.
Credit Capital Investments first reported a position in Merck in Q4 2021 and held it in 1 quarter.
Credit Capital Investments's Merck position peaked at $613K in Q4 2021.
2,953 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Credit Capital Investments's 13F filing for Q1 2022, filed 16 May 2022.